{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T20:01:12Z","timestamp":1760385672415,"version":"3.41.2"},"reference-count":16,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,2,20]],"date-time":"2019-02-20T00:00:00Z","timestamp":1550620800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","award":["55187"],"award-info":[{"award-number":["55187"]}],"id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"DOI":"10.3389\/fmed.2019.00031","type":"journal-article","created":{"date-parts":[[2019,2,20]],"date-time":"2019-02-20T04:11:39Z","timestamp":1550635899000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Comparative Efficacies of Linezolid vs. Tedizolid in an Experimental Murine Model of Vancomycin-Resistant Enterococcal (VRE) Bacteremia"],"prefix":"10.3389","volume":"6","author":[{"given":"Wessam","family":"Abdelhady","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nagendra N.","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2019,2,20]]},"reference":[{"key":"B1","article-title":"Comparison of linezolid and daptomycin in an experimental murine model of VRE faecium bacteremia; emergence of daptomycin \u2013 nonsusceptibility during daptomycin treatment","volume-title":"ICAAC (Interscience conference on Antimicrobial Agents and Chemotherapy) Meeting, Poster # 1365","author":"Xiong","year":""},{"key":"B2","article-title":"Murine model of acute vancomycin-resistant enterococcal (VRE) bacteremia","volume-title":"ICAAC meeting, Poster # 1351","author":"Xiong","year":""},{"key":"B3","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.diagmicrobio.2014.08.011","article-title":"Results of the surveillance of tedizolid activity and resistance program: in vitro susceptibility of gram-positive pathogens collected in 2011 and 2012 from the United States and Europe. Diagn","volume":"81","author":"Sahm Deane","year":"2015","journal-title":"Microbiol Infect Dis"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e43958","DOI":"10.1371\/journal.pone.0043958","article-title":"Daptomycin resistance in enterococci is associated with distinct alterations of cell membrane phospholipid content","volume":"7","author":"Mishra","year":"2012","journal-title":"PLoS ONE"},{"key":"B5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.12688\/f1000research.11831.1","article-title":"Vancomycin-resistant enterococcus infection in the hematopoietic stem cell transplant recipient: an overview of epidemiology, management, and prevention","volume":"7","author":"Benamu","year":"2018","journal-title":"F1000 Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1056\/NEJMoa1011138","article-title":"Genetic basis for in vivo daptomycin resistance in enterococci","volume":"365","author":"Arias","year":"2011","journal-title":"N Engl J Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1007\/s00284-018-1491-3","article-title":"Prevention of high-level daptomycin-resistance emergence in vitro in Streptococcus mitis-oralis by using combination antimicrobial strategies","volume":"75","author":"Zapata","year":"2018","journal-title":"Curr Microbiol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.1093\/cid\/cit615","article-title":"Use of pharmacokinetic\/pharmacodynamic systems analyses to inform dose selection of tedizolid phosphate","volume":"58","author":"Lodise","year":"2014","journal-title":"Clin Infect Dis"},{"key":"B9","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1080\/00498250210158249","article-title":"Pharmacokinetics, toxicokinetics, distribution, metabolism and excretion of linezolid in mouse, rat and dog","volume":"32","author":"Slatter","year":"2002","journal-title":"Xenobiotica"},{"key":"B10","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1086\/338514","article-title":"Inhibition of intracellular macromolecular synthesis in Staphylococcus aureus by thrombin-induced platelet microbicidal proteins","volume":"185","author":"Xiong","year":"2002","journal-title":"J Infect Dis."},{"key":"B11","doi-asserted-by":"publisher","first-page":"e71151","DOI":"10.1371\/journal.pone.0071151","article-title":"Emergence of daptomycin resistance in daptomycin-na\u00efve rabbits with methicillin-resistant Staphylococcus aureus prosthetic joint infection is associated with resistance to host defense cationic peptides and mprF polymorphisms","volume":"8","author":"Mishra","year":"2013","journal-title":"PLoS ONE"},{"key":"B12","doi-asserted-by":"publisher","first-page":"4713","DOI":"10.1128\/AAC.00346-12","article-title":"Activity of tedizolid phosphate (TR-701) in murine models of infection with penicillin-resistant and penicillin-sensitive Streptococcus pneumoniae","volume":"56","author":"Choi","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1128\/AAC.06427-11","article-title":"Comparative in vivo efficacies of epithelial lining fluid exposures of tedizolid, linezolid, and vancomycin for methicillin-resistant Staphylococcus aureus in a mouse pneumonia model","volume":"56","author":"Tessier","year":"2012","journal-title":"Antimicrob Agents Chemother."},{"key":"B14","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.1128\/AAC.05354-11","article-title":"Pulmonary disposition of tedizolid following administration of once-daily oral 200-milligram tedizolid phosphate in healthy adult volunteers","volume":"56","author":"Housman","year":"2012","journal-title":"Antimicrob Agents Chemother."},{"key":"B15","doi-asserted-by":"publisher","first-page":"5092","DOI":"10.1128\/AAC.00880-16","article-title":"Comparative efficacies of tedizolid phosphate, linezolid, and vancomycin in a murine model of subcutaneous catheter-related biofilm infection due to methicillin-susceptible and -resistant Staphylococcus aureus","volume":"60","author":"Bayer","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"B16","doi-asserted-by":"publisher","first-page":"fnx284","DOI":"10.1093\/femsle\/fnx284","article-title":"Effect of tedizolid on clinical Enterococcus isolates: in vitro activity, distribution of virulence factor, resistance genes and multilocus sequence typing","volume":"365","author":"Bai","year":"2018","journal-title":"FEMS Microbiol Lett"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmed.2019.00031\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,20]],"date-time":"2019-02-20T04:11:43Z","timestamp":1550635903000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmed.2019.00031\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,20]]},"references-count":16,"alternative-id":["10.3389\/fmed.2019.00031"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2019.00031","relation":{},"ISSN":["2296-858X"],"issn-type":[{"type":"electronic","value":"2296-858X"}],"subject":[],"published":{"date-parts":[[2019,2,20]]},"article-number":"31"}}